{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:10:59Z","timestamp":1770747059178,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ando.2008.02.013","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T09:29:30Z","timestamp":1208338170000},"page":"153-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["New immunomodulators in the treatment of Graves\u2019 ophthalmopathy"],"prefix":"10.1016","volume":"69","author":[{"given":"M.","family":"Salvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Campi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Curr\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Beck-Peccoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2008.02.013_bib1","first-page":"19615","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ando.2008.02.013_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2005-1018","article-title":"T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin\u20131 beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy","volume":"147","author":"Han","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2008.02.013_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2006.02.047","article-title":"Pathogenesis of Graves\u2019 ophthalmopathy: implications for prediction, prevention and treatment","volume":"142","author":"Garrity","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ando.2008.02.013_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.ando.2008.02.013_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2008.02.013_bib6","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant expression of the insulin-like growth factor-1 receptor by T-cells from patients with Graves\u2019 disease may carry functional consequences for disease pathogenessis","volume":"178","author":"Douglas","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ando.2008.02.013_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.0.1430197","article-title":"Serum concentrations of proinflammatory cytokines in Graves\u2019 disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking","volume":"143","author":"Salvi","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2008.02.013_bib8","first-page":"168","article-title":"Management of Graves\u2019ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2008.02.013_bib9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids \u2013 New mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2008.02.013_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.52.735","article-title":"Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves\u2019 disease","volume":"52","author":"Kubota","year":"2005","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2008.02.013_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2265.2004.02143.x","article-title":"Clinical results of anti-inflammatory therapy in Graves\u2019 ophthalmopathy and association with thyroidal auto-antibodies","volume":"61","author":"Eckstein","year":"2004","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.ando.2008.02.013_bib12","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157: pathophysiology of Graves\u2019 ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.ando.2008.02.013_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1186\/ar1688","article-title":"The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator fro the treatment of rheumatoid arthritis","volume":"7","author":"Ruderman","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ando.2008.02.013_bib14","first-page":"153","article-title":"Can interleukin-10 be used as a true immunoregulatory cytokine?","volume":"11","author":"Wakkach","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.ando.2008.02.013_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/187153006779025694","article-title":"Anti-interleukin-6 receptor antibody therapy in rheumatic diseases","volume":"6","author":"Nakahara","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.ando.2008.02.013_bib16","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1056\/NEJMp048114","article-title":"B Cells, Be Gone- B-Cell depletion in the treatment of rheumatoid arthritis","volume":"350","author":"Tsokos GC","year":"2004","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ando.2008.02.013_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ando.2008.02.013_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/eje.1.02119","article-title":"Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression","volume":"154","author":"Salvi","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2008.02.013_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/thy.2006.16.709","article-title":"Treatment-resistant severe, active Graves\u2019 ophthalmopathy successfully treated with B lymphocyte depletion","volume":"16","author":"El Fassi","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2008.02.013_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","article-title":"Treatment of Graves\u2019 disease and associated ophthalmopathy with the anti-CD 20 monoclonal antibody rituximab: an open study","volume":"156","author":"Salvi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2008.02.013_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ando.2008.02.013_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-2004-13301","article-title":"In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD 20 monoclonal antibody","volume":"13","author":"Sidner","year":"2004","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.ando.2008.02.013_bib23","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/art.20592","article-title":"Rituximab improves peripheral B-cell abnormalities in human systemic lupus erythematosus","volume":"50","author":"Anolik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ando.2008.02.013_bib24","unstructured":"Male D, Cooke A, Owen M, Trowsdale J, Champion B. Antigen receptor molecules. In: Advanced Immunology. London: Mosby: 1996. p. 2.1\u20132.2."},{"key":"10.1016\/j.ando.2008.02.013_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/en.2005-1305","article-title":"Are there more than antibodies to the thryoid-stimulating hormone receptor that meet the eye in Graves\u2019 disease?","volume":"147","author":"Drexhage","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2008.02.013_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2006.02.005","article-title":"B-cells as antigen presenting cells","volume":"238","author":"Rodriguez-Pinto","year":"2005","journal-title":"Cell Immunol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426608000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426608000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:52Z","timestamp":1757716972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426608000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0003426608000516"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2008.02.013","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New immunomodulators in the treatment of Graves\u2019 ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2008.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}